abrdn Healthcare Investors SEC Filings

HQH NYSE

Welcome to our dedicated page for abrdn Healthcare Investors SEC filings (Ticker: HQH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking why abrdn Healthcare Investors (HQH) raised its managed distribution to 10 % means digging into hundreds of pages that detail biotech holdings, NAV drivers, and leverage policy. Instead of opening every N-CSR and N-PORT by hand, use Stock Titan’s AI-powered summaries to see what changed, which biotech positions moved the discount to NAV, and how new healthcare deals shift risk.

Below you’ll find every filing—from an abrdn Healthcare Investors annual report 10-K simplified to an abrdn Healthcare Investors 8-K material events explained—indexed the moment EDGAR releases it. Our platform answers the searches investors actually ask:

“abrdn Healthcare Investors insider trading Form 4 transactions”
“Where is the abrdn Healthcare Investors quarterly earnings report 10-Q filing?”
“How do I read an abrdn Healthcare Investors proxy statement executive compensation?”

For each document, Stock Titan delivers:

Form 4 alerts for abrdn Healthcare Investors Form 4 insider transactions real-time, spotlighting executive stock moves.
Clear language that makes abrdn Healthcare Investors SEC filings explained simply a reality.
Concise tables that power abrdn Healthcare Investors earnings report filing analysis without spreadsheets.

Whether you’re understanding abrdn Healthcare Investors SEC documents with AI to monitor clinical-stage biotech exposure or measuring income stability, our coverage of N-CSR, N-Q, 10-Q, 8-K, DEF 14A, and N-PX is complete. Investors use these insights to:

Check distribution sustainability against portfolio cash flows.
Review new diagnostics or pharmaceutical positions ahead of FDA milestones.
Compare insider trends through abrdn Healthcare Investors executive stock transactions Form 4.

Open any filing below and let Stock Titan’s expert analysis surface the metrics that matter.

07/22/2025 02:39 PM

Filing

[Form 3] abrdn Healthcare Investors Initial Statement of Beneficial Ownership

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of abrdn Healthcare Investors (HQH)?

The current stock price of abrdn Healthcare Investors (HQH) is $16.15 as of July 23, 2025.

What is the market cap of abrdn Healthcare Investors (HQH)?

The market cap of abrdn Healthcare Investors (HQH) is approximately 840.3M.

What is the primary objective of abrdn Healthcare Investors (HQH)?

The primary objective is to seek long-term capital appreciation by investing in securities of healthcare companies.

Which sectors does abrdn Healthcare Investors focus on?

The fund focuses on biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, healthcare IT and services.

What recent changes have been made to the distribution policy?

In February 2024, abrdn Healthcare Investors announced a 25% increase in its managed distribution policy rate, raising it from 8% to 10%.

How does the fund benchmark its performance?

The fund benchmarks its performance against the Nasdaq Biotechnology Index and the S&P 500 Index.

What factors are considered in the fund's fundamental analysis?

Factors include market position, management experience, technological expertise, and the ability to generate or secure capital for growth.

What is the outlook for the healthcare sector according to abrdn Healthcare Investors?

The outlook is optimistic, driven by an aging population, increasing healthcare expenditures, and continuous medical innovation.

How can investors contact abrdn Healthcare Investors for more information?

Investors can contact abrdn U.S. Closed-End Funds Investor Relations at 1-800-522-5465 or email Investor.Relations@abrdn.com.

Does the fund invest in both public and private companies?

Yes, the fund invests in both public and private companies within the healthcare sector.

What type of companies does abrdn Healthcare Investors primarily target?

The fund primarily targets growth stocks of small-cap companies in the healthcare sector.

What is the significance of the recent mergers and acquisitions in the healthcare sector for the fund?

Recent mergers and acquisitions have positively impacted the portfolio, with clinical trial successes and new product approvals boosting investor confidence.